Zung To's most recent trade in Kezar Life Sciences Inc was a trade of 7,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kezar Life Sciences Inc | Zung To | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 7,000 | 7,000 | - | - | Employee Stock Option (right to buy) |